| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 65, 1187-1191, Copyright © 1987 by Endocrine Society
ARTICLES |
T Watabe, K Tanaka, M Kumagae, S Itoh, F Takeda, K Morio, M Hasegawa, T Horiuchi, S Miyabe and N Shimizu
Third Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Insulin-induced hypoglycemia is a potent stress stimulating ACTH release, but the factors responsible for this ACTH secretion are not known. In this study, several ACTH-stimulating factors, such as CRH, arginine vasopressin (AVP), epinephrine (E), norepinephrine (NE), and dopamine, in addition to ACTH, cortisol, and glucose, were simultaneously measured in plasma before and 15, 30, 60, 90, and 120 min after iv administration of 0.1 U/kg BW regular insulin to seven normal subjects. Insulin administration resulted in significant rises in the mean plasma ACTH level from 4.6 +/- 1.1 (+/- SEM) to 21.6 +/- 4.8 pmol/L at 30 min (P less than 0.01) and in plasma cortisol from 330 +/- 60 to 720 +/- 50 nmol/L at 60 min (P less than 0.01). These increases were preceded by a 41.0 +/- 1.9% (P less than 0.001) fall in blood glucose levels. The mean plasma CRH level rose significantly from 1.0 +/- 0.1 to 1.2 +/- 0.1 pmol/L (P less than 0.01) at 30 min and remained elevated until 120 min. In addition, concomitant and significant rises in plasma AVP levels (basal, 1.5 +/- 0.01; peak, 4.5 +/- 1.1 pmol/L at 30 min; P less than 0.01), E (basal, less than 50; peak, 640 +/- 130 pmol/L at 30 min; P less than 0.01), and NE (basal, 0.07 +/- 0.01; peak, 0.17 +/- 0.03 nmol/L at 60 min; P less than 0.05), but not dopamine, also occurred. These results suggest that multiple ACTH-releasing factors, such as CRH, AVP, E, and NE, are involved in ACTH secretion induced by insulin-induced hypoglycemia in man.
This article has been cited by other articles:
![]() |
G. I. Lancaster, Q. Khan, P. T. Drysdale, F. Wallace, A. E. Jeukendrup, M. T. Drayson, and M. Gleeson Effect of prolonged exercise and carbohydrate ingestion on type 1 and type 2 T lymphocyte distribution and intracellular cytokine production in humans J Appl Physiol, February 1, 2005; 98(2): 565 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamamoto, I. Morimoto, Y. Tanaka, N. Yanagihara, and S. Eto The Mutual Regulation of Arginine-Vasopressin and PTHrP Secretion in Dissociated Supraoptic Neurons Endocrinology, April 1, 2002; 143(4): 1521 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pacak and M. Palkovits Stressor Specificity of Central Neuroendocrine Responses: Implications for Stress-Related Disorders Endocr. Rev., August 1, 2001; 22(4): 502 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Nye, J. E. Grice, G. I. Hockings, C. R. Strakosch, G. V. Crosbie, M. M. Walters, and R. V. Jackson Comparison of Adrenocorticotropin (ACTH) Stimulation Tests and Insulin Hypoglycemia in Normal Humans: Low Dose, Standard High Dose, and 8-Hour ACTH-(1-24) Infusion Tests J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3648 - 3655. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Muscelli, M. Emdin, A. Natali, L. Pratali, S. Camastra, A. Gastaldelli, S. Baldi, C. Carpeggiani, and E. Ferrannini Autonomic and Hemodynamic Responses to Insulin in Lean and Obese Humans J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2084 - 2090. [Abstract] [Full Text] |
||||
![]() |
S. Yamamoto, I. Morimoto, K. Zeki, Y. Ueta, H. Yamashita, H. Kannan, and S. Eto Centrally Administered Parathyroid Hormone (PTH)-Related Protein(1-34) But Not PTH(1-34) Stimulates Arginine-Vasopressin Secretion and Its Messenger Ribonucleic Acid Expression in Supraoptic Nucleus of the Conscious Rats Endocrinology, January 1, 1998; 139(1): 383 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamamoto, I. Morimoto, N. Yanagihara, K. Zeki, T. Fujihira, F. Izumi, H. Yamashita, and S. Eto Parathyroid Hormone-Related Peptide-(1-34) [PTHrP- (1-34)] Induces Vasopressin Release from the Rat Supraoptic Nucleus in Vitro through a Novel Receptor Distinct from a Type I or Type II PTH/PTHrP Receptor Endocrinology, May 1, 1997; 138(5): 2066 - 2072. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Nye, G. I. Hockings, J. E. Grice, D. J. Torpy, M. M. Walters, G. V. Crosbie, M. Wagenaar, M. Cooper, and R. V. Jackson Aspirin Inhibits Vasopressin-Induced Hypothalamic-Pituitary-Adrenal Activity in Normal Humans J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 812 - 817. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |